Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Pharma (NUVB)

Logo korporat perusahaan Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. (NUVB) attracts top researchers through its scientific culture and stock options. The projected one-year forward growth in net income per share confirms this potential, with the 32.70 metric serving as the target level. Business stability relies on US centers and new drugs, while current success depends on management's integration of acquired assets.

Nuvation Pharma (NUVB): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 15.11.2026

Ringkesan rincian data analitis Nuvation Pharma (NUVB)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Nuvation Bio Inc.
Produk dadi Nuvation Bio Inc

Professional managers utilize fundamental metrics to filter assets, assessing return potential through analyst consensus forecasts for net earnings per share growth rates. This indicator measures expected EPS dynamics, which in the case of Nuvation Bio Inc. (NUVB) reflects the commercialization of late-stage oncology developments and patent protection, determining investment attractiveness via the valuation of next year's EPS growth.

Analisis pesaing Nuvation Bio Inc.

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Day One Biopharmaceuticals Inc (DAWN)|MNPR - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Inhibrx Biosciences Inc INBX|I-Mab - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|FENC - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep herontx.com|NVCT: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Coherus CHRS|Prakiraan wutah bathi saben saham kanggo taun ngarep CRBP|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardiff Oncology CRDF|Prakiraan wutah bathi saben saham kanggo taun ngarep BYSI (BeyondSpring Inc.)|BCAB (BioAtla Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Lixte Biotechnology - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep CTXR (Citius Pharma)|Cellectar - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BLRX (BioLineRx Corp)|CANF: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea (APRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kaziatherapeutics.com|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)